Valuation check: BHTG's ROE is -66.7%, below the Utilities sector average of 11.24%.
Get informed when a big investor buys or sells
+ Follow-66.70%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
BioHiTech Global (BHTG) currently reports a ROE of -66.7%. That is below the Utilities sector average of 11.24%. Use the charts on this page to explore BioHiTech Global's ROE history and peer comparisons.
BioHiTech Global's ROE of -66.7% is lower than the Utilities sector average of 11.24%. That is roughly 693.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but BioHiTech Global's current -66.7% should be judged against Utilities norms (sector average: 11.24%) and against BHTG's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -66.7%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Utilities average is 11.24%. From there, open related valuation or income-statement pages for BioHiTech Global, and consider following BHTG for alerts when major investors trade the stock.
BioHiTech Global is classified in the Utilities sector. On ROE, it currently shows -66.7% versus a sector average near 11.24%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Utilities are usually more informative than comparing BHTG with unrelated industries.